2021 American Transplant Congress

Monday, June 7, 2021

5:00pm-5:05pm

MDR-101-MLK-MERCURY Kidney Transplant Tolerance Study Update

D. Kaufman¹, S. Akkina², M. Stegall³, J. Piper⁴, A. O. Gaber⁵, E. Marin⁶, S. Busque⁷, D. Alonso⁸, M. De Vera⁹, A. Shah¹⁰, A. Patel¹¹, K. Chavin¹², M. Laftavi¹³, S. Collette¹⁴, E. Stites¹⁵, M. Mai¹⁶, M. Cooper¹⁷, D. Brennan¹⁸

Biomarkers, Immune Assessment and Clinical Outcomes - III  •  Virtual

5:00pm-5:05pm

Outcomes After Liver Transplantation With Steatotic Grafts: Redefining Acceptable Cutoffs for Moderately Steatotic Grafts

B. L. Da¹, J. Satiya², R. P. Heda³, Y. Jiang⁴, L. Lau⁵, A. Fahmy¹, A. Winnick¹, N. Roth¹, E. Grodstein¹, P. J. Thuluvath⁶, A. K. Singal⁷, T. D. Schiano⁸, L. W. Teperman¹, S. K. Satapathy¹

Liver Recipient Selection  •  Virtual

5:00pm-5:05pm

The Learning Curve Associated with De Novo Tacrolimus XR Use in a Racially Diverse Kidney Transplant Population

F. Bartlett, T. Carcella, N. Patel, V. Rohan, D. Taber

Quality Assurance and Regulatory Issues  •  Virtual

5:05pm-5:10pm

Dd-cfdna Can Guide Safe Reintroduction of Immunosuppression in Kidney Transplant Recipients with Covid-19

J. Miles¹, J. Leonard², V. Tatapudi², M. Fei¹, R. Montgomery², N. M. Ali²

Late-Breaking: COVID-19  •  Virtual

5:05pm-5:10pm

Early Stent Removal in Kidney Transplant Recipients – A Quality Improvement Project

V. Rohan, N. Pilch, M. Altiti, S. Nadig, A. Lin, D. DuBay, P. Baliga

Quality Assurance and Regulatory Issues  •  Virtual

5:05pm-5:10pm

Impact of a Pharmacist-driven Immunization Clinic on Vaccination Rates in Pre-liver Transplant Patients

A. Poparad-Stezar¹, B. Summers¹, M. Fitzmaurice¹, K. Hakamiun², N. Sulejmani³, A. Jantz¹

Infectious Disease Poutpouri  •  Virtual

5:05pm-5:10pm

Kidney Transplant Rejection Can Be Diagnosed or Even Predicted by Tracking Donor Reactive T Cell Clones in Post-transplant Samples

Y. Sambandam¹, M. Kandpal¹, J. He¹, X. Huang¹, T. S. Taylor¹, A. A. Shetty², J. M. Mathew¹, J. R. Leventhal¹

Biomarkers, Immune Assessment and Clinical Outcomes - III  •  Virtual

5:05pm-5:10pm

Risk Stratification of Kidney Transplant Patients According to the Different Level of HLA-DQ Disparities

A. Senev¹, A. R. Tambur², M. Naesens¹

B cell/Antibody and Histocompatibility  •  Virtual

5:05pm-5:10pm

The Utility of PET/ CT Testing in Cardiac Risk Stratification of Adult Liver Transplant Candidates

M. A. Tincopa¹, R. Weinberg¹, S. Sengupta¹, J. Slivnick², J. Corbett¹, C. Sonnenday¹, R. Fontana¹, P. Sharma¹

Liver Recipient Selection  •  Virtual

5:05pm-5:10pm

Therapeutic Response of Late Clinical Cell Mediated Rejection is Modeled by Chronicity Changes

I. Melgarejo¹, V. Visnawathan², A. Sharma¹, P. Sood¹, C. Puttarajappa¹, C. Wu¹, N. Shah¹, M. Molinari¹, S. Hariharan¹, R. Mehta¹

Kidney: Acute Cellular Rejection  •  Virtual